These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10404879)
41. Animal-free culture process for manufacture of viral vaccines: process validation and regulatory perspectives. Pierard I; Mareschal JC; Gonze MM; DuchĂȘne M Dev Biol (Basel); 2006; 123():283-90; discussion 291-308. PubMed ID: 16566454 [No Abstract] [Full Text] [Related]
42. An animal origin perspective of common constituents of serum-free medium formulations. Jayme DW Dev Biol Stand; 1999; 99():181-7. PubMed ID: 10404889 [TBL] [Abstract][Full Text] [Related]
43. Technologies for the control of fat and lean deposition in livestock. Sillence MN Vet J; 2004 May; 167(3):242-57. PubMed ID: 15080873 [TBL] [Abstract][Full Text] [Related]
44. Control of recombinant DNA produced pharmaceuticals by a combination of process validation and final product specifications. Jones AJ; O'Connor JV Dev Biol Stand; 1985; 59():175-80. PubMed ID: 4007276 [TBL] [Abstract][Full Text] [Related]
45. Neospora caninum antibodies in commercial fetal bovine serum. Torres MP; Ortega YR Vet Parasitol; 2006 Sep; 140(3-4):352-5. PubMed ID: 16697531 [TBL] [Abstract][Full Text] [Related]
46. A safer plasma supply from remunerated donors--"The Immuno/Community Bio-Resources experiment". Waytes AT; Igel H; Zerlauth G; Wappler N; Lee M; Schwarz O Dev Biol (Basel); 2000; 102():37-51. PubMed ID: 10794089 [TBL] [Abstract][Full Text] [Related]
47. Serological status for N. caninum, bovine viral diarrhea virus, and infectious bovine rhinotracheitis virus at pregnancy testing and reproductive performance in beef herds. Waldner CL Anim Reprod Sci; 2005 Dec; 90(3-4):219-42. PubMed ID: 15893892 [TBL] [Abstract][Full Text] [Related]
48. Bovine viral diarrhoea virus control in Finland 1998-2004. Rikula U; Nuotio L; Aaltonen T; Ruoho O Prev Vet Med; 2005 Nov; 72(1-2):139-42; discussion 215-9. PubMed ID: 16182393 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of surveillance strategies for bovine tuberculosis (Mycobacterium bovis) using an individual based epidemiological model. Fischer EA; van Roermund HJ; Hemerik L; van Asseldonk MA; de Jong MC Prev Vet Med; 2005 Mar; 67(4):283-301. PubMed ID: 15748757 [TBL] [Abstract][Full Text] [Related]
52. Durably controlling bovine hypodermosis. Boulard C Vet Res; 2002; 33(5):455-64. PubMed ID: 12387483 [TBL] [Abstract][Full Text] [Related]
53. Mousepox resulting from use of ectromelia virus-contaminated, imported mouse serum. Lipman NS; Perkins S; Nguyen H; Pfeffer M; Meyer H Comp Med; 2000 Aug; 50(4):426-35. PubMed ID: 11020163 [TBL] [Abstract][Full Text] [Related]
54. Approaches to the release of a master cell bank of PER.C6 cells; a novel cell substrate for the manufacture of human vaccines. Lewis JA; Brown EL; Duncan PA Dev Biol (Basel); 2006; 123():165-76; discussion 183-97. PubMed ID: 16566444 [TBL] [Abstract][Full Text] [Related]
55. The effect of becoming BVDV-free on fertility and udder health in Dutch dairy herds. Berends IM; Swart WA; Frankena K; Muskens J; Lam TJ; van Schaik G Prev Vet Med; 2008 Apr; 84(1-2):48-60. PubMed ID: 18155307 [TBL] [Abstract][Full Text] [Related]
56. Gamma irradiation of bovine sera. Plavsic MZ; Daley JP; Danner DJ; Weppner DJ Dev Biol Stand; 1999; 99():95-109. PubMed ID: 10404881 [No Abstract] [Full Text] [Related]
57. Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products. Schiff LJ In Vitro Cell Dev Biol Anim; 2005; 41(3-4):65-70. PubMed ID: 16029074 [TBL] [Abstract][Full Text] [Related]
58. Australia's campaign to eradicate bovine tuberculosis: the battle for freedom and beyond. Cousins DV; Roberts JL Tuberculosis (Edinb); 2001; 81(1-2):5-15. PubMed ID: 11463220 [TBL] [Abstract][Full Text] [Related]